CONMED Corp (NYSE: CNMD) stock suffered a major decline of -11.6% on 4/25/24. The shares closed at $61.90. Moreover, this decline was accompanied by exceptionally high trading volume at 495% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -14.9% during the last week.
Current PriceTarget Research Rating
CNMD is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
CONMED has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. CONMED has a slightly negative Appreciation Score of 34 and a very low Power Rating of 12, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment